Navigation Links
BioMedomics, Inc. Closes $690K Round of Financing
Date:1/14/2014

Triangle Park, NC. BioMedomics is developing advanced highly sensitive and quantitative rapid POC diagnostic platforms and novel disease specific diagnostic tests for the $16 billion POC diagnostic market. The company’s goal is to make POC testing widely accessible with the same level of sensitivity and quantitation as complex and expensive central lab tests.

The core competencies of the company are a strong combination of biology, biochemistry, and biomedical engineering expertise that underline its technology and product development. To meet the increasing need for improved sensitivity in POC diagnostics the company is developing its next generation Time Resolved and Nanotube platforms. Both of these platforms have the potential for sensitivity below the one picogram/mL level. The company also has a particular expertise in developing POC tests for Drugs of Abuse/Overdose and hemoglobinopathies. Tests currently under development include acetaminophen overdose, Sickle Cell Disease, Alpha Thalassemia, and Heparin Induced Thrombocytopenia, among others.

Read the full story at http://www.prweb.com/releases/2014/01/prweb11480517.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Radius Closes $27.65 Million Second Tranche of Previously Announced Financing
2. Avaxia Biologics, Inc. Closes $4.1 Million Series A Financing to Advance Oral Antibodies for Inflammatory Bowel Disease
3. OncoSec Closes $7.75 Million Public Offering
4. AyoxxA Biosystems Closes Series A Financing Round
5. Enviva Closes on $120 Million Senior Secured Credit Facility
6. Avelas Biosciences Closes $7.65 Million Series A, Advances Real-Time Tumor Visualization Technology Toward Development
7. Biscayne Pharmaceuticals Closes $1.5 Million Financing To Advance Recent Discoveries Of Pioneering Endocrine Drug Researcher
8. Nasseo, Inc. Joins BioInspire™ Medical Technology Incubator, Closes Seed Funding Round
9. Aratana Closes $10 Million Non-Dilutive Financing with Square 1 Bank
10. iBio, Inc. closes $4.2 million public offering and terminates At-the-market offering
11. Westchester Library Closes Due to Bed Bugs, My Cleaning Products Recommends Pesticide-Exempt Bed Bug Spray to Officials and Others Suffering from the Pests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... February 27, 2015 Immunovaccine Inc. ... immunotherapy company, today announced that the U.S. Food ... Fast Track designation and Phase I clinical trials ... with the mutual co-development agreement signed with Gilead ... Track designation for the DPX-Survivac. , “We have ...
(Date:2/27/2015)... Feb. 27, 2015 Bionomics Limited (ASX:BNO, ADR:BMICY) ... trial of BNC105 in patients with metastatic renal cancer ... Orlando, Florida . The data will be presented ... of Hope Comprehensive Cancer Center in California ... The new data identifies Ferritin and IL-8 as two ...
(Date:2/27/2015)... Illinois (PRWEB) February 27, 2015 FamilyFarms ... Sims, General Manager of State Line Farms, received the ... recognizes a producer, under the age of 35, who ... "It is an honor to win the Tomorrow's Top ... discovering who won the Top Producer Award and learning ...
(Date:2/27/2015)... Calif. , Feb. 27, 2015  Steep Hill, ... the US and internationally, intends to open a full ... Albuquerque, New Mexico , bringing advanced scientific tools ... cannabis. Steep Hill is currently the only ... to conduct potency and contaminant testing in order to ...
Breaking Biology Technology:Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 2New BNC105 Biomarker Data to be Presented at US Cancer Conference 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 4New BNC105 Biomarker Data to be Presented at US Cancer Conference 5Matt Sims Receives the 2015 Tomorrow’s Top Producer Horizon Award 2Steep Hill First to Receive Provisional Approval to Establish Laboratory Services for Cannabis Testing in State of New Mexico 2
... the University of California, Berkeley, have turned a ... structures that mimic collagen, one of the most ... developed could eventually be used to manufacture materials ... The researchers, led by Seung-Wuk Lee, UC ...
... giving scientists unprecedented views of the processes that affect ... a familiar tool in nanoscience the Scanning Tunneling ... Atomic and Solid State Physics have been able to ... of a "heavy fermion" compound made of uranium, ruthenium ...
... Physicians and scientists from Reproductive Medicine Associates of ... their groundbreaking research study entitled Cleavage Stage ... Blastocyst Biopsy Does Not: A Novel Paired Analysis ... The study, led by Richard T. Scott, M.D. ...
Cached Biology Technology:Researchers turn viruses into molecular Legos 2Researchers turn viruses into molecular Legos 3Using new technique, scientists uncover a delicate magnetic balance for superconductivity 2Revolutionary IVF Study May Change the Way Embryos are Biopsied for Genetic Disease 2Revolutionary IVF Study May Change the Way Embryos are Biopsied for Genetic Disease 3
(Date:2/12/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ... authentication company focused on the growing mobile commerce market, ... for DISTRIBUTED METHOD AND SYSTEM TO IMPROVE ... further establishes NXT-ID,s position in the emerging "Internet of ... ability for multiple devices to collaborate with one another ...
(Date:2/5/2015)... Feb. 5, 2015  Marken is starting its 35 ... has launched a new marketing campaign to solidify its ... The new campaign focuses on First as ... shipments. The first headline in the series, ... priorities with its client,s priorities. Marken recognizes the need ...
(Date:2/5/2015)... Jan. 28, 2015 NXT-ID, Inc. (NASDAQ: ... a biometric authentication company focused on the growing mobile ... RedChip Global Online CEO Conference on January 29 th ... Gino Pereira , CEO of NXT-ID will present and ... the Wocket smart wallet and its full suite of ...
Breaking Biology News(10 mins):NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3Marken Launches New Patient-Centric Campaign 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3
... was used to help monitor the health of Florida's coral ... August and September. , The project was the first comprehensive ... Marine Sanctuary that stretches about 300 miles from Martin County ... trying to determine why some reefs are resilient to environmental ...
... a radically new strategy featuring radioactive "guided missiles," researchers ... University have successfully targeted and destroyed human immune cells ... , "This study in mice supports the idea that ... says Dr. Arturo Casadevall, chair of the department of ...
... Technology is helping scientists better understand how bone cells work ... that can speed up the time it takes to heal ... Hannay has built a gadget capable of promoting bone cell ... device replicated the mechanical and electrical stimulants which occurred naturally ...
Cached Biology News:NASA satellite data helps assess the health of Florida's coral reef 2NASA satellite data helps assess the health of Florida's coral reef 3Einstein researchers demonstrate a novel approach to treating AIDS 2Einstein researchers demonstrate a novel approach to treating AIDS 3Smashing the time it takes to repair our bones 2
homeo box D3, mRNA...
SNARE associated protein snapin, clone MGC:2717...
Human Serpin A8/AGT Affinity Purified Polyclonal Ab Keywords: Ang II, AngII, Hypertension, Salt Homeostasis, Pre-eclampsia...
Human/Mouse G9a/EHMT2 MAb (Clone A8620A) Keywords: Eu-HMTase2...
Biology Products: